Open177.060 | Close- |
Vol / Avg.573.474K / 1.808M | Mkt Cap81.752B |
Day Range174.970 - 178.085 | 52 Wk Range124.350 - 194.990 |
Zoetis Stock (NYSE: ZTS) stock price, news, charts, stock research, profile.
Open177.060 | Close- |
Vol / Avg.573.474K / 1.808M | Mkt Cap81.752B |
Day Range174.970 - 178.085 | 52 Wk Range124.350 - 194.990 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.320 | 1.410 | 0.0900 | ||||
REV | 2.170B | 2.180B | 10.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-12 | Stifel | Jonathan Block | Reiterates | BuyBuy | Maintains | - | 205.00 |
2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 230.00 |
2023-08-28 | Stifel | Jonathan Block | Maintains | BuyBuy | Raises | 195.00 | 205.00 |
2023-08-14 | Piper Sandler | David Westenberg | Maintains | OverweightOverweight | Raises | 210.00 | 220.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ZTS | Zoetis | 0.55% | 81.8B |
NVO | Novo Nordisk | 0.71% | 411.3B |
RETA | Reata Pharmaceuticals | 0.06% | 6.6B |
JNJ | Johnson & Johnson | -0.43% | 387.6B |
MRK | Merck & Co | -0.04% | 270.7B |
You can purchase shares of Zoetis (NYSE: ZTS) through any online brokerage.
Other companies in Zoetis’s space includes: Novo Nordisk (NYSE:NVO), Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK) and Novartis (NYSE:NVS).
The latest price target for Zoetis (NYSE: ZTS) was reported by Stifel on Tuesday, September 12, 2023. The analyst firm set a price target for 205.00 expecting ZTS to rise to within 12 months (a possible 15.43% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Zoetis (NYSE: ZTS) is $177.6 last updated Today at September 22, 2023 at 5:13 PM UTC.
A quarterly cash dividend of $0.38 per share of Class A Common Stock. The quarterly cash dividend was payable on September 1, 2023 to stockholders of record on July 20, 2023.
Zoetis’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Zoetis.
Zoetis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Zoetis Stock (NYSE: ZTS) stock price, news, charts, stock research, profile.
Open177.060 | Close- |
Vol / Avg.573.474K / 1.808M | Mkt Cap81.752B |
Day Range174.970 - 178.085 | 52 Wk Range124.350 - 194.990 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.320 | 1.410 | 0.0900 | ||||
REV | 2.170B | 2.180B | 10.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-12 | Stifel | Jonathan Block | Reiterates | BuyBuy | Maintains | - | 205.00 |
2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 230.00 |
2023-08-28 | Stifel | Jonathan Block | Maintains | BuyBuy | Raises | 195.00 | 205.00 |
2023-08-14 | Piper Sandler | David Westenberg | Maintains | OverweightOverweight | Raises | 210.00 | 220.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ZTS | Zoetis | 0.55% | 81.8B |
NVO | Novo Nordisk | 0.71% | 411.3B |
RETA | Reata Pharmaceuticals | 0.06% | 6.6B |
JNJ | Johnson & Johnson | -0.43% | 387.6B |
MRK | Merck & Co | -0.04% | 270.7B |
You can purchase shares of Zoetis (NYSE: ZTS) through any online brokerage.
Other companies in Zoetis’s space includes: Novo Nordisk (NYSE:NVO), Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK) and Novartis (NYSE:NVS).
The latest price target for Zoetis (NYSE: ZTS) was reported by Stifel on Tuesday, September 12, 2023. The analyst firm set a price target for 205.00 expecting ZTS to rise to within 12 months (a possible 15.43% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Zoetis (NYSE: ZTS) is $177.6 last updated Today at September 22, 2023 at 5:13 PM UTC.
A quarterly cash dividend of $0.38 per share of Class A Common Stock. The quarterly cash dividend was payable on September 1, 2023 to stockholders of record on July 20, 2023.
Zoetis’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Zoetis.
Zoetis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Zoetis Stock (NYSE: ZTS) stock price, news, charts, stock research, profile.
Open177.060 | Close- |
Vol / Avg.573.474K / 1.808M | Mkt Cap81.752B |
Day Range174.970 - 178.085 | 52 Wk Range124.350 - 194.990 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.320 | 1.410 | 0.0900 | ||||
REV | 2.170B | 2.180B | 10.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-12 | Stifel | Jonathan Block | Reiterates | BuyBuy | Maintains | - | 205.00 |
2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 230.00 |
2023-08-28 | Stifel | Jonathan Block | Maintains | BuyBuy | Raises | 195.00 | 205.00 |
2023-08-14 | Piper Sandler | David Westenberg | Maintains | OverweightOverweight | Raises | 210.00 | 220.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ZTS | Zoetis | 0.55% | 81.8B |
NVO | Novo Nordisk | 0.71% | 411.3B |
RETA | Reata Pharmaceuticals | 0.06% | 6.6B |
JNJ | Johnson & Johnson | -0.43% | 387.6B |
MRK | Merck & Co | -0.04% | 270.7B |
You can purchase shares of Zoetis (NYSE: ZTS) through any online brokerage.
Other companies in Zoetis’s space includes: Novo Nordisk (NYSE:NVO), Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK) and Novartis (NYSE:NVS).
The latest price target for Zoetis (NYSE: ZTS) was reported by Stifel on Tuesday, September 12, 2023. The analyst firm set a price target for 205.00 expecting ZTS to rise to within 12 months (a possible 15.43% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Zoetis (NYSE: ZTS) is $177.6 last updated Today at September 22, 2023 at 5:13 PM UTC.
A quarterly cash dividend of $0.38 per share of Class A Common Stock. The quarterly cash dividend was payable on September 1, 2023 to stockholders of record on July 20, 2023.
Zoetis’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Zoetis.
Zoetis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Zoetis Stock (NYSE: ZTS) stock price, news, charts, stock research, profile.
Open177.060 | Close- |
Vol / Avg.573.474K / 1.808M | Mkt Cap81.752B |
Day Range174.970 - 178.085 | 52 Wk Range124.350 - 194.990 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.320 | 1.410 | 0.0900 | ||||
REV | 2.170B | 2.180B | 10.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-12 | Stifel | Jonathan Block | Reiterates | BuyBuy | Maintains | - | 205.00 |
2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 230.00 |
2023-08-28 | Stifel | Jonathan Block | Maintains | BuyBuy | Raises | 195.00 | 205.00 |
2023-08-14 | Piper Sandler | David Westenberg | Maintains | OverweightOverweight | Raises | 210.00 | 220.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ZTS | Zoetis | 0.55% | 81.8B |
NVO | Novo Nordisk | 0.71% | 411.3B |
RETA | Reata Pharmaceuticals | 0.06% | 6.6B |
JNJ | Johnson & Johnson | -0.43% | 387.6B |
MRK | Merck & Co | -0.04% | 270.7B |
You can purchase shares of Zoetis (NYSE: ZTS) through any online brokerage.
Other companies in Zoetis’s space includes: Novo Nordisk (NYSE:NVO), Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK) and Novartis (NYSE:NVS).
The latest price target for Zoetis (NYSE: ZTS) was reported by Stifel on Tuesday, September 12, 2023. The analyst firm set a price target for 205.00 expecting ZTS to rise to within 12 months (a possible 15.43% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Zoetis (NYSE: ZTS) is $177.6 last updated Today at September 22, 2023 at 5:13 PM UTC.
A quarterly cash dividend of $0.38 per share of Class A Common Stock. The quarterly cash dividend was payable on September 1, 2023 to stockholders of record on July 20, 2023.
Zoetis’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Zoetis.
Zoetis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Zoetis Stock (NYSE: ZTS) stock price, news, charts, stock research, profile.
Open177.060 | Close- |
Vol / Avg.573.474K / 1.808M | Mkt Cap81.752B |
Day Range174.970 - 178.085 | 52 Wk Range124.350 - 194.990 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.320 | 1.410 | 0.0900 | ||||
REV | 2.170B | 2.180B | 10.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-12 | Stifel | Jonathan Block | Reiterates | BuyBuy | Maintains | - | 205.00 |
2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 230.00 |
2023-08-28 | Stifel | Jonathan Block | Maintains | BuyBuy | Raises | 195.00 | 205.00 |
2023-08-14 | Piper Sandler | David Westenberg | Maintains | OverweightOverweight | Raises | 210.00 | 220.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ZTS | Zoetis | 0.55% | 81.8B |
NVO | Novo Nordisk | 0.71% | 411.3B |
RETA | Reata Pharmaceuticals | 0.06% | 6.6B |
JNJ | Johnson & Johnson | -0.43% | 387.6B |
MRK | Merck & Co | -0.04% | 270.7B |
You can purchase shares of Zoetis (NYSE: ZTS) through any online brokerage.
Other companies in Zoetis’s space includes: Novo Nordisk (NYSE:NVO), Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK) and Novartis (NYSE:NVS).
The latest price target for Zoetis (NYSE: ZTS) was reported by Stifel on Tuesday, September 12, 2023. The analyst firm set a price target for 205.00 expecting ZTS to rise to within 12 months (a possible 15.43% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Zoetis (NYSE: ZTS) is $177.6 last updated Today at September 22, 2023 at 5:13 PM UTC.
A quarterly cash dividend of $0.38 per share of Class A Common Stock. The quarterly cash dividend was payable on September 1, 2023 to stockholders of record on July 20, 2023.
Zoetis’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Zoetis.
Zoetis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Zoetis Stock (NYSE: ZTS) stock price, news, charts, stock research, profile.
Open177.060 | Close- |
Vol / Avg.573.474K / 1.808M | Mkt Cap81.752B |
Day Range174.970 - 178.085 | 52 Wk Range124.350 - 194.990 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.320 | 1.410 | 0.0900 | ||||
REV | 2.170B | 2.180B | 10.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-12 | Stifel | Jonathan Block | Reiterates | BuyBuy | Maintains | - | 205.00 |
2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 230.00 |
2023-08-28 | Stifel | Jonathan Block | Maintains | BuyBuy | Raises | 195.00 | 205.00 |
2023-08-14 | Piper Sandler | David Westenberg | Maintains | OverweightOverweight | Raises | 210.00 | 220.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ZTS | Zoetis | 0.55% | 81.8B |
NVO | Novo Nordisk | 0.71% | 411.3B |
RETA | Reata Pharmaceuticals | 0.06% | 6.6B |
JNJ | Johnson & Johnson | -0.43% | 387.6B |
MRK | Merck & Co | -0.04% | 270.7B |
You can purchase shares of Zoetis (NYSE: ZTS) through any online brokerage.
Other companies in Zoetis’s space includes: Novo Nordisk (NYSE:NVO), Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK) and Novartis (NYSE:NVS).
The latest price target for Zoetis (NYSE: ZTS) was reported by Stifel on Tuesday, September 12, 2023. The analyst firm set a price target for 205.00 expecting ZTS to rise to within 12 months (a possible 15.43% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Zoetis (NYSE: ZTS) is $177.6 last updated Today at September 22, 2023 at 5:13 PM UTC.
A quarterly cash dividend of $0.38 per share of Class A Common Stock. The quarterly cash dividend was payable on September 1, 2023 to stockholders of record on July 20, 2023.
Zoetis’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Zoetis.
Zoetis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Zoetis Stock (NYSE: ZTS) stock price, news, charts, stock research, profile.
Open177.060 | Close- |
Vol / Avg.573.474K / 1.808M | Mkt Cap81.752B |
Day Range174.970 - 178.085 | 52 Wk Range124.350 - 194.990 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.320 | 1.410 | 0.0900 | ||||
REV | 2.170B | 2.180B | 10.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-12 | Stifel | Jonathan Block | Reiterates | BuyBuy | Maintains | - | 205.00 |
2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 230.00 |
2023-08-28 | Stifel | Jonathan Block | Maintains | BuyBuy | Raises | 195.00 | 205.00 |
2023-08-14 | Piper Sandler | David Westenberg | Maintains | OverweightOverweight | Raises | 210.00 | 220.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ZTS | Zoetis | 0.55% | 81.8B |
NVO | Novo Nordisk | 0.71% | 411.3B |
RETA | Reata Pharmaceuticals | 0.06% | 6.6B |
JNJ | Johnson & Johnson | -0.43% | 387.6B |
MRK | Merck & Co | -0.04% | 270.7B |
You can purchase shares of Zoetis (NYSE: ZTS) through any online brokerage.
Other companies in Zoetis’s space includes: Novo Nordisk (NYSE:NVO), Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK) and Novartis (NYSE:NVS).
The latest price target for Zoetis (NYSE: ZTS) was reported by Stifel on Tuesday, September 12, 2023. The analyst firm set a price target for 205.00 expecting ZTS to rise to within 12 months (a possible 15.43% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Zoetis (NYSE: ZTS) is $177.6 last updated Today at September 22, 2023 at 5:13 PM UTC.
A quarterly cash dividend of $0.38 per share of Class A Common Stock. The quarterly cash dividend was payable on September 1, 2023 to stockholders of record on July 20, 2023.
Zoetis’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Zoetis.
Zoetis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Zoetis Stock (NYSE: ZTS) stock price, news, charts, stock research, profile.
Open177.060 | Close- |
Vol / Avg.573.474K / 1.808M | Mkt Cap81.752B |
Day Range174.970 - 178.085 | 52 Wk Range124.350 - 194.990 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.320 | 1.410 | 0.0900 | ||||
REV | 2.170B | 2.180B | 10.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-12 | Stifel | Jonathan Block | Reiterates | BuyBuy | Maintains | - | 205.00 |
2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 230.00 |
2023-08-28 | Stifel | Jonathan Block | Maintains | BuyBuy | Raises | 195.00 | 205.00 |
2023-08-14 | Piper Sandler | David Westenberg | Maintains | OverweightOverweight | Raises | 210.00 | 220.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ZTS | Zoetis | 0.55% | 81.8B |
NVO | Novo Nordisk | 0.71% | 411.3B |
RETA | Reata Pharmaceuticals | 0.06% | 6.6B |
JNJ | Johnson & Johnson | -0.43% | 387.6B |
MRK | Merck & Co | -0.04% | 270.7B |
You can purchase shares of Zoetis (NYSE: ZTS) through any online brokerage.
Other companies in Zoetis’s space includes: Novo Nordisk (NYSE:NVO), Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK) and Novartis (NYSE:NVS).
The latest price target for Zoetis (NYSE: ZTS) was reported by Stifel on Tuesday, September 12, 2023. The analyst firm set a price target for 205.00 expecting ZTS to rise to within 12 months (a possible 15.43% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Zoetis (NYSE: ZTS) is $177.6 last updated Today at September 22, 2023 at 5:13 PM UTC.
A quarterly cash dividend of $0.38 per share of Class A Common Stock. The quarterly cash dividend was payable on September 1, 2023 to stockholders of record on July 20, 2023.
Zoetis’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Zoetis.
Zoetis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
Zoetis Stock (NYSE: ZTS) stock price, news, charts, stock research, profile.
Open177.060 | Close- |
Vol / Avg.573.474K / 1.808M | Mkt Cap81.752B |
Day Range174.970 - 178.085 | 52 Wk Range124.350 - 194.990 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 1.320 | 1.410 | 0.0900 | ||||
REV | 2.170B | 2.180B | 10.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-12 | Stifel | Jonathan Block | Reiterates | BuyBuy | Maintains | - | 205.00 |
2023-09-06 | HSBC | Morten Herholdt | Initiates Coverage On | Buy | Announces | - | 230.00 |
2023-08-28 | Stifel | Jonathan Block | Maintains | BuyBuy | Raises | 195.00 | 205.00 |
2023-08-14 | Piper Sandler | David Westenberg | Maintains | OverweightOverweight | Raises | 210.00 | 220.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ZTS | Zoetis | 0.55% | 81.8B |
NVO | Novo Nordisk | 0.71% | 411.3B |
RETA | Reata Pharmaceuticals | 0.06% | 6.6B |
JNJ | Johnson & Johnson | -0.43% | 387.6B |
MRK | Merck & Co | -0.04% | 270.7B |
You can purchase shares of Zoetis (NYSE: ZTS) through any online brokerage.
Other companies in Zoetis’s space includes: Novo Nordisk (NYSE:NVO), Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK) and Novartis (NYSE:NVS).
The latest price target for Zoetis (NYSE: ZTS) was reported by Stifel on Tuesday, September 12, 2023. The analyst firm set a price target for 205.00 expecting ZTS to rise to within 12 months (a possible 15.43% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Zoetis (NYSE: ZTS) is $177.6 last updated Today at September 22, 2023 at 5:13 PM UTC.
A quarterly cash dividend of $0.38 per share of Class A Common Stock. The quarterly cash dividend was payable on September 1, 2023 to stockholders of record on July 20, 2023.
Zoetis’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Zoetis.
Zoetis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.